Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Shigeru Tsuyuki"'
Publikováno v:
Surgical Case Reports, Vol 6, Iss 1, Pp 1-5 (2020)
Abstract Background Breast angiosarcoma (AS) is a rare malignant breast tumor arising from endothelial cells lining the blood vessels. The prognosis of AS is reportedly poor. However, the effectiveness of chemotherapy and radiation is still controver
Externí odkaz:
https://doaj.org/article/4c7f06d298224a9a8a9c6743cb27b605
Autor:
Nobuko Kawaguchi-Sakita, Noriko Senda, Yukiko Inagaki-Kawata, Hiromi Murakami, Sayaka Honda, Takahiro Yamada, Yuki Kataoka, Shoko Takahara, Shigeru Tsuyuki, Kazuhiko Yamagami, Yoshio Moriguchi, Masae Torii, Tatsushi Kato, Hirofumi Suwa, Wakako Tsuji, Eiji Suzuki, Akira Yamauchi, Ryuji Okamura, Shinji Kosugi, Masakazu Toi
Publikováno v:
Cancer Research. 83:P2-05
[Introduction] Personalized health care is recommended for the prevention and early detection of breast cancer. Advances in technology have made it possible to estimate genetic risk, PGV (pathogenic/likely-pathogenic germline variant) or PRS (polygen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::453971011d367876fdff63036c492ed5
https://doi.org/10.1158/1538-7445.sabcs22-p2-05-02
https://doi.org/10.1158/1538-7445.sabcs22-p2-05-02
Autor:
Tomoyuki Aruga, Hiroyoshi Doihara, Yasuhiro Yanagita, Takanori Ishida, Toshinari Yamashita, Kanou Uehara, Tetsuhiko Taira, Junji Tsurutani, Takashi Takeshita, Shigeru Tsuyuki, Koji Kaneko, Tohru Ohtake, Yusuke Yamaguchi, Yui Hara, Shigehira Saji
Publikováno v:
Cancer Science. 113:1763-1770
Pegfilgrastim, a pegylated form of granulocyte colony-stimulating factor, has reduced the risk of developing febrile neutropenia, which is associated with an increase in severe infection and prolonged hospitalization. However, pegfilgrastim administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28804cd0c1edaf7af132b6dae87a0f23
https://doi.org/10.1111/cas.15335
https://doi.org/10.1111/cas.15335
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(11)
We evaluated the efficacy of surgical glove(SG)-compression therapy for paclitaxel (PTX)-induced peripheral neuropathy (PN)and the impact of PN prevention on treatment duration. Patients with advanced or metastatic breast cancer underwent a combined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d0f39965f679a2c53e2285a909149ce
https://pubmed.ncbi.nlm.nih.gov/36412028
https://pubmed.ncbi.nlm.nih.gov/36412028
Autor:
Kaori Togashi, Akira Yamauchi, Hironori Kato, Nobuhiko Shinkura, Kenichi Yoshida, Kosuke Kawaguchi, Takahiro Yamada, Ryuji Okamura, Masahiro Sugimoto, Eiji Suzuki, Hironori Haga, Masae Torii, Hirofumi Suwa, Norimichi Kan, Sachiko Takahara, Yoshiaki Matsumoto, Masahiro Kawashima, Tsuyoshi Tachibana, Masakazu Toi, Yukiko Inagaki-Kawata, Hiroshi Yoshibayashi, Takashi Inamoto, Masako Kataoka, Shingo Sakata, Nobuko Kawaguchi-Sakita, Fumiaki Yotsumoto, Kazuhiko Yamagami, Yuki Kataoka, Mitsuru Tanaka, Shinji Kosugi, Masahiro Takada, Seishi Ogawa, Shigeru Tsuyuki, Tomomi Nishimura, Susumu Mashima, Noriko Senda, Yoshio Moriguchi
Publikováno v:
Cancer Science
Predicting pathogenic germline variants (PGVs) in breast cancer patients is important for selecting optimal therapeutics and implementing risk reduction strategies. However, PGV risk factors and the performance of prediction methods in the Japanese p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21bafd3a7488cd234e791c5630dc4892
http://hdl.handle.net/2433/277559
http://hdl.handle.net/2433/277559
Autor:
Hiroyasu Yamashiro, Tetsuya Taguchi, Nobuko Ogura, Tomoharu Sugie, Masakazu Toi, Ichiro Nakayama, Hiroshi Ishiguro, Shigeru Tsuyuki, Yuri Fujimoto, Tatsuji Kato, Sachiko Takahara, Hiroshi Yoshibayashi, Masahiro Takada, Tatsuo Kagimura, Yoshio Moriguchi, Kazuhiko Yamagami, Rie Yasuoka, Takeshi Kotake, Hirofumi Suwa, Yuichiro Kikawa, Toshitaka Okuno
Publikováno v:
Cancer Research. 81:PS13-31
BackgroundEribulin (E) is a chemotherapeutic drug that prolongs overall survival (OS) of patients with HER2-negative advanced or metastatic breast cancer (AMBC), mainly in multi-line chemotherapy (ChT) or later. However, the effectiveness and optimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a344127d16b868c85ad3b61db4f9c11
https://doi.org/10.1158/1538-7445.sabcs20-ps13-31
https://doi.org/10.1158/1538-7445.sabcs20-ps13-31
Autor:
Takashi Inamoto, Fumiaki Yotsumoto, Masahiro Kawashima, Masae Torii, Hiroshi Yoshibayashi, Masakazu Toi, Akira Yamauchi, Kenichi Yoshida, Nobuko Kawaguchi-Sakita, Mitsuru Tanaka, Shingo Sakata, Masahiro Sugimoto, Hirofumi Suwa, Nobuhiko Shinkura, Shigeru Tsuyuki, Yukiko Inagaki-Kawata, Yuki Kataoka, Yoshiaki Matsumoto, Tomomi Nishimura, Norimichi Kan, K Yamagami, Ryuji Okamura, Susumu Mashima, Fumiaki Sato, Hironori Kato, Yoshio Moriguchi, Noriko Senda, Tsuyoshi Tachibana, Masahiro Takada, Seishi Ogawa, Eiji Suzuki
Publikováno v:
Cancer Research. 80:P2-10
Background: Breast cancer risk models are used to predict the risk of carrying a variant, for one of the most common breast cancer susceptibility genes such as BRCA1 and BRCA2, and the lifetime risk of developing breast cancer. The prediction of harb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ce4e60b1ede049cf36eba438eea22c5
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-12
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-12
Autor:
Yuichiro Kikawa, Takeshi Kotake, Shigeru Tsuyuki, Yookija Kang, Sachiko Takahara, Yuri Fujimoto, Hiroyasu Yamashiro, Hiroshi Yoshibayashi, Masahiro Takada, Rie Yasuoka, Katsuhiko Nakatsukasa, Kazuhiko Yamagami, Hirofumi Suwa, Toshitaka Okuno, Ichiro Nakayama, Tatsushi Kato, Nobuko Ogura, Yoshio Moriguchi, Hiroshi Ishiguro, Tatsuo Kagimura, Tetsuya Taguchi, Tomoharu Sugie, Masakazu Toi
Publikováno v:
Breast cancer (Tokyo, Japan). 29(5)
The optimal positioning of eribulin treatment remains unclear. This study aimed to investigate the effectiveness of eribulin administration as first- and second-line chemotherapy in patients with endocrine-resistant advanced or metastatic breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16e5c2cd0d16e662ed9a8529f8fd4e3
https://pubmed.ncbi.nlm.nih.gov/35460066
https://pubmed.ncbi.nlm.nih.gov/35460066
Publikováno v:
Int Cancer Conf J
Although various first- to third-line HER2-targeted therapies have been established, the optimal sequence after third-line therapy has not been determined yet. Here, we describe seven patients with HER2-positive metastatic breast cancer who underwent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f718db1e06c779b7984505b7ecdb413
https://europepmc.org/articles/PMC8421475/
https://europepmc.org/articles/PMC8421475/
Autor:
Shigeru Tsuyuki, Hiroshi Yoshibayashi, Sachiko Takahara, Nobuko Ogura, Akira Yamauchi, Toshitaka Okuno, Takashi Inamoto, Satoru Tanaka, Yuichiro Kikawa, Takashi Hashimoto, Haruko Takuwa, Tomoharu Sugie, Yutaka Mizuno, Kazuhiko Yamagami, Hironori Kato, Hiroyasu Yamashiro, Tatsushi Kato, Toshiro Katayama
Publikováno v:
The Breast. 47:22-27
Background We have developed a surgical glove (SG)-compression therapy and reported that this method significantly reduced the overall occurrence of grade 2 or higher nanoparticle albumin-bound-paclitaxel (nab-PTX)-induced peripheral neuropathy (PN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1507ab856f769c81d95cd500c06ab96a
https://doi.org/10.1016/j.breast.2019.06.008
https://doi.org/10.1016/j.breast.2019.06.008